<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Singlera-Genomics on 生物经济</title><link>https://cn.bioecon.ru/companies/singlera-genomics/</link><description>Recent content in Singlera-Genomics on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Mon, 20 Jul 2026 16:20:20 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/companies/singlera-genomics/index.xml" rel="self" type="application/rss+xml"/><item><title>多癌种早期检测（MCED）</title><link>https://cn.bioecon.ru/technology/multi-cancer-early-detection/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/multi-cancer-early-detection/</guid><description>通过一次抽血即可对无症状、平均风险人群同时筛查数十种癌症信号，旨在症状出现前发现癌症——区别于与治疗挂钩的伴随诊断：美国的 GRAIL Galleri、Exact Sciences 的 Cancerguard 与 Freenome，瑞士的 Novigenix，以及中国的泛生子（Singlera Genomics）。</description></item></channel></rss>